GB9303632D0 - Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element - Google Patents

Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element

Info

Publication number
GB9303632D0
GB9303632D0 GB939303632A GB9303632A GB9303632D0 GB 9303632 D0 GB9303632 D0 GB 9303632D0 GB 939303632 A GB939303632 A GB 939303632A GB 9303632 A GB9303632 A GB 9303632A GB 9303632 D0 GB9303632 D0 GB 9303632D0
Authority
GB
United Kingdom
Prior art keywords
azaquinoline
angiotensin
quinoline
substituted biphenyl
antagonists incorporating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB939303632A
Other versions
GB2264710A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9303632D0 publication Critical patent/GB9303632D0/en
Publication of GB2264710A publication Critical patent/GB2264710A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
GB9303632A 1992-03-04 1993-02-23 Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element Withdrawn GB2264710A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84588192A 1992-03-04 1992-03-04

Publications (2)

Publication Number Publication Date
GB9303632D0 true GB9303632D0 (en) 1993-04-07
GB2264710A GB2264710A (en) 1993-09-08

Family

ID=25296317

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9303632A Withdrawn GB2264710A (en) 1992-03-04 1993-02-23 Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element

Country Status (1)

Country Link
GB (1) GB2264710A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484794A (en) * 1994-11-09 1996-01-16 Eli Lilly And Company Method for treating anxiety
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
EP1094816B1 (en) * 1998-07-06 2008-12-10 Bristol-Myers Squibb Company Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
JP2003520785A (en) * 1999-12-15 2003-07-08 ブリストル−マイヤーズ スクイブ カンパニー Biphenylsulfonamides as angiotensin and endothelin receptor dual antagonists
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
RU2011102587A (en) * 2008-06-25 2012-07-27 Энвиво Фармасьютикалз, Инк. (Us) DISPLACED PHENIL COMPOUNDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903966A0 (en) * 1989-08-11 1990-08-10 Ici Plc KVAEVEFOERENINGAR.
IE903911A1 (en) * 1989-11-20 1991-05-22 Ici Plc Diazine derivatives

Also Published As

Publication number Publication date
GB2264710A (en) 1993-09-08

Similar Documents

Publication Publication Date Title
IL105877A0 (en) Angiotensin ii antagonists
EP0515535A4 (en) Angiotensin ii antagonists incorporating a substituted benzyl element
AU1228792A (en) Substituted pyridinones and pyrimidinones as angiotensin ii antagonists
GB2269836B (en) Composite roofing element
GB2269837B (en) Fence coupling
EP0515546A4 (en) Triazole angiotensin ii antagonists incorporating a substituted benzyl element
EP0723556A4 (en) Fas antagonists and uses thereof
EP0586613A4 (en) Bradykinin antagonists
GB9317760D0 (en) Angiotensin ii antagonist
IL107400A0 (en) Bradykinin antagonists
EP0729472A4 (en) Piperidinylcamphorsulfonyl oxytocin antagonists
AU3276293A (en) Angiotensin II receptor antagonists
IL109782A0 (en) Imidazole-5-position substituted angiotensin II antagonists and pharmaceutical compositions containing them
EP0543491A3 (en) Angiotensin ii antagonists having a substituted 1,3-benzodioxolering or 1,3-benzodithiolering
GB9317758D0 (en) Angiotensin ii antagonist
SG50426A1 (en) Lhrh antagonists
EP0515548A4 (en) Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
GB9301047D0 (en) Substituted pyrimidinones as neurotensin antagonists
GB9303632D0 (en) Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted biphenyl element
ZA934536B (en) Angiotensin IV peptides and receptors
EP0546449A3 (en) Benzofuranderivatives as angiotensin ii antagonists
GB9306489D0 (en) Oxytocin antagonists
IL120336A0 (en) Angiotensin II antagonists
GB9217033D0 (en) Angiotensin ii antagonists incorporating a substituted benzyl element
GB9216958D0 (en) Angiotensin ii antagonists incorporating a substituted benzyl element

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)